Navigation Links
Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
Date:11/30/2011

LAUSANNE, Switzerland, November 30, 2011 /PRNewswire/ --

Current Ceo Rudi Pauwels Becomes Executive Chairman Focusing On Scientific And Technology Strategy


New Ceo Appointment Strengthens Commercial Focus As Biocartis Prepares For Launch Of Its First Product In 2013

Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive personalized medicine and improve the diagnosis of disease, today announced the appointment of Dr. Nayan Gregory Parekh as its new Chief Executive Officer.

Parekh brings to Biocartis a wealth of pharmaceutical and biotechnology industry experience and has been an Executive Director of the Company's Board since April 2011. Rudi Pauwels, co-founder of Biocartis and current CEO, will become Executive Chairman and will dedicate his time to the Company's scientific and technology strategy.

Biocartis is moving into a new strategic phase as it focuses on building commercial capabilities and expanding industry partnerships. Dr. Parekh has held senior management positions at Novartis and Deutsche Bank and has a broad network of relationships and experience across a number of healthcare fields and geographies. Most recently, he was at New Rhein Healthcare LLC, a healthcare investment firm where he was one of the founding partners.  Before setting up New Rhein, Dr. Parekh spent six years as head of corporate development at Novartis AG, where he led the Novartis investments in Eye Care, Vaccines, Diagnostics, Generics, as well as certain emerging markets such as China, Saudi Arabia, Brazil and Russia.   He was also a member of the Novartis Group Finance Committee. Prior to joining Novartis in 2004, he spent ten years in investment banking, primarily&#
'/>"/>

SOURCE Biocartis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
2. bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics
3. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
4. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
5. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
6. Rhythm Names Keith M. Gottesdiener Chief Executive Officer
7. FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech
8. OXIS International Names David Saloff as Chief Executive Officer
9. Numira Biosciences Names New Board Member
10. PrimeraDx Names Fayyaz Memon Vice President of Regulatory Affairs and Quality Assurance
11. Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to ... Switzerland -based Kenta Biotech to ... antibody (mAb) products, and technologies. This asset portfolio ... treatment of infections by common pathogens including drug ... Pseudomonas aeruginosa , Acinetobacter baumannii ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says ... been known to react more aggressively when hormones change, and ... puberty, other acne causing factors like P.acnes bacteria and excess ... with unsightly acne scars. Adult acne treatment, Probiotic Action shares ... how to reduce and prevent acne scarring. , In order ...
(Date:5/17/2013)... MD (PRWEB) May 17, 2013 ... of ezColony version 4.1, a versatile refinement to ... premier software solution, improves its advanced methodical management ... facilities with ezColony 4.1. The network-based platform provides ... conduct effective research. While continuing to emphasize streamlined ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... ... and Ralph M. Lerner named Senior Vice President of Commercial Development , ... Marlborough, Mass. (Vocus) October 23, ... technology turns biomass into cellulosic ethanol, has welcomed Kevin F. McLaughlin and Ralph M. ...
... Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ... overview of the Company at the 8th Annual BIO ... 3:00 p.m. PT. The conference will be held at ... and 29, 2009. , A live audio link to ...
... Oct. 23 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on endocrine therapy and ... previously announced registered direct offering of US$5.5 million ... share purchase warrants to certain institutional investors. AEterna ...
Cached Biology Technology:Cellulosic Biofuels Leader Qteros Adds Key Positions 2Cellulosic Biofuels Leader Qteros Adds Key Positions 3Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009 2AEterna Zentaris Receives US$5.5 Million from Institutional Investors 2AEterna Zentaris Receives US$5.5 Million from Institutional Investors 3
(Date:5/17/2013)... and Sustainable Global Logistics Operations) is aiming to cut ... of intermodal loading systems and the boosting of intelligent ... organisations with experience in the logistics sector and in ... and a duration of three and a half years. ... semantic components and ontologies shared by the users, objects ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
(Date:5/16/2013)... 2013) Illustrating a commitment to the support ... Association (AGA) Research Foundation has announced the inaugural ... Award recipients. Supported by the National Institute of ... new award helps underrepresented minority students to further ... research. , "By establishing this new award, AGA ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... in partnership with Oak Ridge National Laboratory (ORNL) will ... the National Science Foundation (NSF) has deemed the "most ... The two will team up to participate ... continental-scale ecological observatory, to answer questions that deal with ...
... Mass. A six-year campaign to control invasive winter ... Elkinton of the University of Massachusetts Amherst now has ... been established and is attacking the pest at four ... beginning of the end for the decade-long defoliation of ...
... (Santa Barbara, Calif.) Sensors made from custom DNA molecules ... quality of stem cells, according to an international team of ... University of Rome Tor Vergata. The new nanosensors can ... which serve as the master control switches of life. The ...
Cached Biology News:University of Tennessee chosen to join national network to study climate change 2UMass Amherst entomologists begin to control winter moth infestation in eastern Massachusetts 2Nanosensors made from DNA may light path to new cancer tests and drugs 2Nanosensors made from DNA may light path to new cancer tests and drugs 3
Peptide-affinity Purified Polyclonal Antibody to Prolactin Releasing Hormone Receptor (GPR10)...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
DNA sequencing - plasmids or PCR fragments, 3-7 working days service....
Biology Products: